Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis.

Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis. PLoS Negl Trop Dis. 2017 04; 11(4):e0005459.

View in: PubMed

subject areas

Administration, Oral
Antiprotozoal Agents
Caregivers
Child
Child, Preschool
Cost-Benefit Analysis
Directly Observed Therapy
Drug Costs
Female
Humans
Injections, Intramuscular
Leishmania
Leishmaniasis, Cutaneous
Male
Meglumine
Monte Carlo Method
Organometallic Compounds
Phosphorylcholine
Sensitivity and Specificity
Treatment Outcome
United States

authors with profiles

Allison H. Bartlett
Mai Tuyet Pho